Javascript must be enabled to continue!
Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa
View through CrossRef
Abstract
Background
The World Health Organization–approved Xpert MTB/XDR test detects Mycobacterium tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and injectable drugs directly in specimens. This pragmatic, laboratory-based study assessed the diagnostic accuracy and feasibility of a reflex testing approach, where Xpert MTB/XDR was performed on residual specimens previously processed for Xpert MTB/RIF Ultra.
Methods
Routine respiratory specimens, processed for Xpert MTB/RIF Ultra, were stored in sample reagent buffer at 2°C–8°C. If rifampicin resistant, the residual specimen was assessed for adequate volume (≥2 mL) and tested with Xpert MTB/XDR, with storage time recorded. A second specimen was used for routine and reference standard testing (culture and sequencing).
Results
Specimens (99% sputum) from 763 participants submitted to 2 large routine laboratories were included. Xpert MTB/XDR yielded valid resistance detection results in 639 (84%), compared with 507 (66%) for routine testing (difference [95% CI], 18% [13%–22%]). The median turnaround time for results was 23 hours for Xpert MTB/XDR and 15 days for routine testing. While 748 specimens (98%) were ≥2 mL, only 102 (13%) were stored for ≤4 hours. By the reference standard, 284 of 394 (72%) were isoniazid resistant, and 57 of 380 (15%) were fluroquinolone resistant. The sensitivities of Xpert MTB/XDR were 94% (95% CI, 91%–97%) for isoniazid and 91% (81%–97%) for fluoroquinolone resistance detection. The specificities were 98% (94%–100%) and 100% (98%–100%), respectively.
Conclusions
Xpert MTB/XDR performed favorably compared with the reference, and the reflex testing approach increased results availability over routine testing, while dramatically decreasing turnaround time from weeks to hours. Laboratory workflow precluded testing within the manufacturer-recommended 4-hour storage time, but longer storage did not appear detrimental.
Oxford University Press (OUP)
C M Centner
R Munir
E Tagliani
F Rieß
P Brown
C Hayes
T Dolby
W Zemanay
D M Cirillo
A David
S G Schumacher
C M Denkinger
M Ruhwald
V N Leukes
M P Nicol
I Van der Walt
G Kisten
M Gumede
A Mace
A Brink
W Stevens
L Scott
A Penn-Nicholson
H Cox
Vinzeigh Leukes
Adam Penn-Nicholson
Morten Ruhwald
Berra Erkosar
Samuel G Schumacher
Sunita Singh
Bernard Kivuma
Muhuminu Nuru
Judith Mlenge
Neema Shija
Deogratias Bulime
Dorcas Mnzava
Petro Sabuni
Hosiana Temba
Jamali Siru
Jerry Hella
Jonathan Msafiri
Maja Weisser
Mohamed Mbaruku
Mohamed Sasamalo
Alice Leonard
Ambilikile Malango
Annastazia Alexander
Faith Komakoma
Gloria Msigala
Kasmir Johaness
Grace Mhalu
Mwajabu Hamis
Priscilla Mlay
Robert Ndege
Sera Barasa
Swalehe Masoud
Theonestina Byakuzana
Anange Lwilla
Benedict Kayombo
Chacha Mangu
Christina Manyama
Theodora Mbunda
Elimina Siyame
Issa Sabi
Last Mwaipopo
Nyanda Elias Ntinginya
Raphael Edom
Willyhelmina Olomi
Delio Elisio
Dinis Nguenha
Edson Mambuque
Joaquim Cossa
Marta Cossa
Neide Gomes
Patricia Manjate
Shilzia Munguambe
Sozinho Acacio
Belen Saavedra
Helio Chiconela
Katia Ribeiro
António Machiana
Bindiya Meggi
Candido Azize Junior
Carla Madeira
Celso Khosa
Claudio Bila
Denise Floripes
Diosdélio Malamule
Sofia Viegas
Belén Saavedra
Carole Amroune
Joanna Ehrlich
Laura de la Torre Pérez
Sergi Sanz
Albero Garcia-Basteiro
Friedrich Riess
Sarah Mutuku
Tejaswi Appalarowthu
Leyla Larson
Katharina Kranzer
Michael Hoelscher
Norbert Heinrich
Maria del Mar Castro Noriega
Claudia M Denkinger
Saima Arif
Daniela Maria Cirillo
Elisa Tagliani
Federico Di Marco
Virginia Batignani
Akash Malhotra
David Dowdy
Claudia Schacht
Julia Buech
Caroline Stöhr
Marguerite Massinga Loembé
Pascale Ondoa
Nqobile Ndlovu
Fumbani Brown
Yonas Ghebrekristos
Cindy Hayes
Ilse Van der Walt
Shareef Abrahams
Puleng Marokane
Mbuti Radebe
Neil Martinson
Anura David
Lesley Scott
Lucky Ngwenya
Pedro Da Silva
Reyhana Solomon
Wendy Stevens
Charles Abongomera
Klaus Reither
Leon Stieger
Adrian Brink
Chad M Centner
Helen Cox
Judi van Heerden
Mark P Nicol
Nchimunya Hapeela
Parveen Brown
Reyhana Solomon
Widaad Zemanay
Tania Dolby
Title: Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa
Description:
Abstract
Background
The World Health Organization–approved Xpert MTB/XDR test detects Mycobacterium tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and injectable drugs directly in specimens.
This pragmatic, laboratory-based study assessed the diagnostic accuracy and feasibility of a reflex testing approach, where Xpert MTB/XDR was performed on residual specimens previously processed for Xpert MTB/RIF Ultra.
Methods
Routine respiratory specimens, processed for Xpert MTB/RIF Ultra, were stored in sample reagent buffer at 2°C–8°C.
If rifampicin resistant, the residual specimen was assessed for adequate volume (≥2 mL) and tested with Xpert MTB/XDR, with storage time recorded.
A second specimen was used for routine and reference standard testing (culture and sequencing).
Results
Specimens (99% sputum) from 763 participants submitted to 2 large routine laboratories were included.
Xpert MTB/XDR yielded valid resistance detection results in 639 (84%), compared with 507 (66%) for routine testing (difference [95% CI], 18% [13%–22%]).
The median turnaround time for results was 23 hours for Xpert MTB/XDR and 15 days for routine testing.
While 748 specimens (98%) were ≥2 mL, only 102 (13%) were stored for ≤4 hours.
By the reference standard, 284 of 394 (72%) were isoniazid resistant, and 57 of 380 (15%) were fluroquinolone resistant.
The sensitivities of Xpert MTB/XDR were 94% (95% CI, 91%–97%) for isoniazid and 91% (81%–97%) for fluoroquinolone resistance detection.
The specificities were 98% (94%–100%) and 100% (98%–100%), respectively.
Conclusions
Xpert MTB/XDR performed favorably compared with the reference, and the reflex testing approach increased results availability over routine testing, while dramatically decreasing turnaround time from weeks to hours.
Laboratory workflow precluded testing within the manufacturer-recommended 4-hour storage time, but longer storage did not appear detrimental.
Related Results
Evaluasi sensitivitas dan spesifisitas Xpert MTB RIF dan Xpert MTB RIF Ultra pada berbagai spesimen untuk mendiagnosis tuberkulosis ekstra paru: Sebuah telaah literatur sistematis
Evaluasi sensitivitas dan spesifisitas Xpert MTB RIF dan Xpert MTB RIF Ultra pada berbagai spesimen untuk mendiagnosis tuberkulosis ekstra paru: Sebuah telaah literatur sistematis
Background: Molecular examination using Xpert MTB RIF and Xpert MTB RIF Ultra was introduced by WHO in 2010 as a fast and practical supporting examination in detecting Mycobacteriu...
Rapid detection of non-rifampicin drug resistant tuberculosis using Xpert MTB/XDR testing: Findings from a multisite drug-resistant tuberculosis case detection surge in Zambia
Rapid detection of non-rifampicin drug resistant tuberculosis using Xpert MTB/XDR testing: Findings from a multisite drug-resistant tuberculosis case detection surge in Zambia
Abstract
Background
Zambia continues to face a high burden of tuberculosis with rising drug resistance, yet diagnosis of non-ri...
Comparison of tests done, and Tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
Comparison of tests done, and Tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
Abstract
Background
Uganda introduced Xpert® MTB/RIF assay into its TB diagnostic algorithm in January 2012. In July 2018, this...
The Value of Lateral Flow Urine Lipoarabinomannan Assay and Empirical Treatment in the Xpert MTB/RIF Ultra Era: a Prospective Cohort Study
The Value of Lateral Flow Urine Lipoarabinomannan Assay and Empirical Treatment in the Xpert MTB/RIF Ultra Era: a Prospective Cohort Study
Abstract
Introduction: The value of Lateral Flow urine Lipoarabinomannan (LF-LAM) assay and the role of empiric tuberculosis (TB) treatment in the era of the highly sensiti...
Survival and infectivity of mycobacterium tuberculosis after aerosolization
Survival and infectivity of mycobacterium tuberculosis after aerosolization
<p dir="ltr">Tuberculosis (TB) remains the leading cause of death by a single infectious organism with over 1.3 million people succumbing to the disease every year. Despite e...
Prevalence of Mycobacterium Tuberculosis and Rifampicin-Resistant Tuberculosis Among Tuberculosis Presumptive Adults in Northern Ethiopia, 2016-2019
Prevalence of Mycobacterium Tuberculosis and Rifampicin-Resistant Tuberculosis Among Tuberculosis Presumptive Adults in Northern Ethiopia, 2016-2019
Abstract
Background: Tuberculosis (TB) is the second leading cause of mortality from an infectious disease worldwide. Multidrug-resistant tuberculosis (MDR-TB), where rifam...
Comparison evaluation between gene Xpert Mtb/Rif and multiplex PCR for rapid diagnosis of mycobacterium tuberculosis
Comparison evaluation between gene Xpert Mtb/Rif and multiplex PCR for rapid diagnosis of mycobacterium tuberculosis
Abstract
Objective: To evaluate Gene Xpert MTB/RIF and Multiplex PCRfor detection of Mycobacterium tuberculosis and Rifampicin resistance comparing with gold standard MGIT 96...
The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study
The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study
AbstractThe value of Lateral Flow urine Lipoarabinomannan (LF-LAM) assay and the role of empiric tuberculosis (TB) treatment in the era of the highly sensitive Xpert MTB/RIF Ultra ...

